Le Ma
Impact in
- Hepatology top 10%
- Liver Diseases and Immunity
-
- Ion Channels and Receptors
Papers in
-
- Epigenetics and DNA Methylation 3
- Protein Degradation and Inhibitors 2
- Fibroblast Growth Factor Research 2
- Oncology 7
- Cancer-related Molecular Pathways 5
- Co-authors
- W. J. Pledger (5 shared papers)Tapan Bagui (4 shared papers)Ross L. Coppel (1 shared paper)Eric M. Gershwin (1 shared paper)Pietro Invernizzi (1 shared paper)Zhiguang Zhou (1 shared paper)Aftab A. Ansari (1 shared paper)Ana Lleò (1 shared paper)
- Journals
- Cell Cycle (3 papers)Pediatric Rheumatology (2 papers)Hepatology (1 paper)Molecular Neurobiology (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Le Ma
25 papers receiving 385 citations
Peers
Comparison fields: 5 of 74
- Hepatology 78
- Sensory Systems 24
- Rheumatology 44
- Cancer Research 41
- Oncology 67
Countries citing papers authored by Le Ma
This map shows the geographic impact of Le Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Ma more than expected).
Fields of papers citing papers by Le Ma
This network shows the impact of papers produced by Le Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Ma. The network helps show where Le Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Le Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 105 | |
| 2 | 2016 | 39 | |
| 3 | 2018 | 23 | |
| 4 | 2018 | 21 | |
| 5 | 2021 | 19 | |
| 6 | 2022 | 19 | |
| 7 | 2011 | 18 | |
| 8 | 2009 | 17 | |
| 9 | 2013 | 15 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 13 | |
| 12 | 2004 | 11 | |
| 13 | 2015 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2019 | 10 | |
| 16 | 2008 | 9 | |
| 17 | 2019 | 9 | |
| 18 | 2018 | 8 | |
| 19 | 2024 | 6 | |
| 20 | 2020 | 2 |
About Le Ma
Le Ma is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 26 papers that have together received 387 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Epigenetics and DNA Methylation (3 papers), Protein Degradation and Inhibitors (2 papers), Microtubule and mitosis dynamics (2 papers), Breast Cancer Treatment Studies (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Kawasaki Disease and Coronary Complications (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Hepatology (78 citations), Sensory Systems (24 citations), Rheumatology (44 citations), Cancer Research (41 citations) and Oncology (67 citations). Le Ma has collaborated with scholars based in China, United States and Italy. Frequent co-authors include W. J. Pledger, Tapan Bagui, Ross L. Coppel, Eric M. Gershwin, Pietro Invernizzi, Zhiguang Zhou, Aftab A. Ansari, Ana Lleò, Jieyue Liao and Peng Zhang. Their work appears in journals such as Cell Cycle, Pediatric Rheumatology, Hepatology, Molecular Neurobiology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.